Jason P Rhodes
CIK 1577014 · President, CFO and Treasurer · last filed 2026-07-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.91M
Companies
5
Total Filings
53
Lifetime Open-Market Net
-$108.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Director | 2,962 | $27.09 | $80.2K | -$83.28M | 19 | 2026-07-08 |
| Generation Bio Co. (GBIO) Delisted | Director | 0 | $5.34 | $0 | -$18.24M | 14 | 2026-02-09 |
| REPL | Director | 946,000 | $14.62 | $13.83M | -$2.69M | 11 | 2022-04-05 |
| Disc Medicine, Inc. (GMTX) Delisted | Director | — | $13.50 | — | $0 | 1 | 2021-10-06 |
| Epizyme, Inc. (EPZM) Delisted | President, CFO and Treasurer | 138,000 | $1.47 | $202.9K | -$4.54M | 8 | 2014-09-24 |
Recent Filings · Page 3 of 6
53 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-13 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-06 | DYN | Grant (A) | — | $0 | EDGAR |
| 2022-04-05 | REPL | Grant (A) | — | $0 | EDGAR |
| 2021-10-06 | Disc Medicine, Inc. (GMTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-29 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −81,088 | -$2.06M | EDGAR |
| 2021-09-24 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −134,998 | -$3.51M | EDGAR |
| 2021-06-28 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −31,008 | -$801.6K | EDGAR |
| 2021-06-23 | Generation Bio Co. (GBIO) Delisted | Sell (S) | −185,078 | -$4.64M | EDGAR |
| 2021-06-11 | Generation Bio Co. (GBIO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-27 | DYN | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.